Arcutis to Present at the Cantor Fitzgerald Global Healthcare Conference 2020
15 September 2020 - 11:00PM
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage
biopharmaceutical company focused on developing and commercializing
treatments for unmet needs in immune-mediated dermatological
diseases and conditions, or immuno-dermatology, today announced
that Arcutis management will participate in a fireside chat
presentation during the Cantor Fitzgerald Global Healthcare
Conference 2020 taking place Sept. 15-17, 2020.
Details for the presentation are as
follows:
Cantor Fitzgerald Global Healthcare Conference
2020
Presentation Date: Thursday, Sept. 17,
2020
Presentation Time: 7:40 a.m. PT / 10:40 a.m.
ET
The presentation will be webcast and may be
accessed at the “Events & Presentations” section of the
Company’s website at
https://investors.arcutis.com/events-and-presentations . Arcutis
will maintain an archived replay of the webcast on its website for
30 days after the conference.
About Arcutis - Bioscience, applied to the
skin.Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage
biopharmaceutical company focused on developing and commercializing
treatments for unmet needs in immune-mediated dermatological
diseases and conditions, or immuno-dermatology. The company is
leveraging recent advances in immunology and inflammation to
develop differentiated therapies against biologically validated
targets to solve persistent treatment challenges in serious
diseases of the skin. Arcutis’ robust pipeline includes four novel
drug candidates currently in development for a range of
inflammatory dermatological conditions. The company’s lead product
candidate, topical roflumilast, has the potential to revitalize the
standard of care for plaque psoriasis, atopic dermatitis, scalp
psoriasis, and seborrheic dermatitis. For more information,
visit https://www.arcutis.com or follow the company on LinkedIn and
Twitter.
Investors and Media:Heather Rowe ArmstrongVice
President, Investor Relations & Corporate
Communicationsharmstrong@arcutis.com805-418-5006, Ext. 740
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Apr 2024 to May 2024
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From May 2023 to May 2024